• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢匹罗在化脓性脑膜炎患者脑脊液中的扩散。

Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis.

作者信息

Wolff M, Chavanet P, Kazmierczak A, Pechinot A, Dematons C, Portier H, Lenfant B

机构信息

Clinique de Réanimation des Maladies Infectieuses, Hôpital Bichat-Claude Bernard, Paris, France.

出版信息

J Antimicrob Chemother. 1992 Apr;29 Suppl A:59-62. doi: 10.1093/jac/29.suppl_a.59.

DOI:10.1093/jac/29.suppl_a.59
PMID:1601758
Abstract

We evaluated the diffusion of cefpirome into the cerebrospinal fluid (CSF) of 25 patients with bacterial meningitis or ventriculitis who were receiving conventional antibiotic treatment. A single cefpirome dose of 2 g was infused at day 2-3 after the onset of therapy. Concentrations of cefpirome in serum and CSF obtained at 2, 4, 8 or 12 h after the infusion were determined by high-performance liquid chromatography. The mean (+/- S.E.M.) concentrations of cefpirome in CSF ranged from 2.26 +/- 1.16 to 4.17 +/- 0.83 mg/L. These concentrations were higher than the MBCs for the pathogens usually responsible for bacterial meningitis.

摘要

我们评估了头孢匹罗在25例接受传统抗生素治疗的细菌性脑膜炎或脑室炎患者脑脊液(CSF)中的扩散情况。在治疗开始后的第2 - 3天静脉输注2 g单剂量头孢匹罗。输注后2、4、8或12小时采集的血清和脑脊液中头孢匹罗的浓度通过高效液相色谱法测定。脑脊液中头孢匹罗的平均(±标准误)浓度范围为2.26±1.16至4.17±0.83 mg/L。这些浓度高于通常引起细菌性脑膜炎的病原体的最低杀菌浓度。

相似文献

1
Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis.头孢匹罗在化脓性脑膜炎患者脑脊液中的扩散。
J Antimicrob Chemother. 1992 Apr;29 Suppl A:59-62. doi: 10.1093/jac/29.suppl_a.59.
2
[Meningeal diffusion of cefpirome in adults].
Pathol Biol (Paris). 1989 May;37(5):442-5.
3
Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.头孢匹罗在非炎性脑膜患者中的脑脊液穿透情况。
J Antimicrob Chemother. 1992 Apr;29 Suppl A:51-7. doi: 10.1093/jac/29.suppl_a.51.
4
Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.在模拟脑脊液浓度曲线的药效学模型中,头孢匹罗对来自脑膜炎患者的耐青霉素肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1995 Nov;39(11):2560-3. doi: 10.1128/AAC.39.11.2560.
5
Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.羟羧氧酰胺菌素在细菌性脑膜炎患儿脑脊液中的扩散。
J Pediatr. 1981 Dec;99(6):975-9. doi: 10.1016/s0022-3476(81)80036-4.
6
Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.单次静脉给药后细菌性脑膜炎患儿脑脊液中头孢匹罗的浓度。
Antimicrob Agents Chemother. 1998 Jan;42(1):199-201. doi: 10.1128/AAC.42.1.199.
7
Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.接受辅助性皮质类固醇治疗肺炎球菌性脑膜炎的成年患者脑脊液中万古霉素的水平:一项前瞻性多中心观察性研究。
Clin Infect Dis. 2007 Jan 15;44(2):250-5. doi: 10.1086/510390. Epub 2006 Dec 15.
8
Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.3-季铵头孢菌素类抗生素在细菌性脑膜炎患者脑脊液中的扩散。
J Chemother. 1996 Feb;8 Suppl 2:83-90.
9
Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.肺炎链球菌脑膜炎实验动物模型中的一氧化氮浓度和脑脊液参数
Pharmacotherapy. 1998 May-Jun;18(3):612-9.
10
[Analysis of delayed cerebrospinal fluid sterilization of pneumococcal meningitis in children].[儿童肺炎球菌性脑膜炎脑脊液杀菌延迟的分析]
Arch Pediatr. 2008 Dec;15 Suppl 3:S119-25. doi: 10.1016/S0929-693X(08)75494-0.

引用本文的文献

1
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.药物穿透血脑屏障/血脑脊液屏障以治疗中枢神经系统感染。
Clin Microbiol Rev. 2010 Oct;23(4):858-83. doi: 10.1128/CMR.00007-10.
2
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.曲伐沙星单独及与β-内酰胺类药物、利福平或万古霉素联合使用时,针对在脑脊液中可达到的临床浓度下对超广谱头孢菌素具有不同敏感性的肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1999 Oct;43(10):2372-5. doi: 10.1128/AAC.43.10.2372.
3
Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.单次静脉给药后细菌性脑膜炎患儿脑脊液中头孢匹罗的浓度。
Antimicrob Agents Chemother. 1998 Jan;42(1):199-201. doi: 10.1128/AAC.42.1.199.
4
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.头孢匹罗。关于其抗菌活性、药代动力学特性及治疗严重医院感染和发热性中性粒细胞减少症临床疗效的综述。
Drugs. 1997 Jul;54(1):117-40. doi: 10.2165/00003495-199754010-00013.
5
Pharmacokinetics of cefpirome in pediatric patients.头孢匹罗在儿科患者中的药代动力学。
Antimicrob Agents Chemother. 1995 Oct;39(10):2348-9. doi: 10.1128/AAC.39.10.2348.
6
Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.在模拟脑脊液浓度曲线的药效学模型中,头孢匹罗对来自脑膜炎患者的耐青霉素肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1995 Nov;39(11):2560-3. doi: 10.1128/AAC.39.11.2560.
7
Cefpirome clinical pharmacokinetics.头孢匹罗的临床药代动力学。
Clin Pharmacokinet. 1993 Oct;25(4):263-73. doi: 10.2165/00003088-199325040-00002.
8
Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.人体血液与脑脊液间药物交换的药代动力学定量研究。
Eur J Clin Pharmacol. 1993;45(5):469-75. doi: 10.1007/BF00315520.
9
Clinical pharmacokinetics of newer cephalosporins.新型头孢菌素的临床药代动力学
Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003.